BioPharmSignal logoBioPharmSignal

Biotech News

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences

Allogene Therapeutics (ALLO)Allogene TherapeuticsCompany update

SOUTH SAN FRANCISCO, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for cancer and autoimmune disease, today announced that it will participate in the

Related news

ALLOAllogene Therapeutics2026-08-31 12:30 EST

Allogene Therapeutics Announces Participation in September Investor Conference

ALLOAllogene Therapeutics2026-10-29 12:30 EST

Allogene Therapeutics Announces November Investor Events Highlighting Q3 Results and Initial ALLO-329 Autoimmune Clinical Data

View all latest news

Allogene Therapeutics

Allogeneic CAR T Company Allogene Therapeutics develops off-the-shelf CAR T-cell therapies for cancer and autoimmune disease. Its platform is intended to provide readily available treatment without patient-specific cell collection and manufacturing. Cema-Cel Cemacabtagene ansegedleucel, or cema-cel, is a CD19-directed AlloCAR T candidate...

Recent company news

ALLOAllogene Therapeutics2026-11-05 21:02 EST

Allogene Therapeutics Reports Third Quarter 2026 Financial Results and Business Update

ALLOAllogene Therapeutics2026-11-03 13:00 EST

Allogene Highlights Clinical Progress and Next-Generation Innovation Across Its Off-the-Shelf CAR T Platform at SITC Annual Meeting

ALLOAllogene Therapeutics2026-10-29 12:30 EST

Allogene Therapeutics Announces November Investor Events Highlighting Q3 Results and Initial ALLO-329 Autoimmune Clinical Data

ALLOAllogene Therapeutics2026-10-26 12:30 EST

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences

ALLOAllogene Therapeutics2026-09-02 12:30 EST

Allogene Therapeutics Announces Retirement of Chief Financial Officer Geoffrey Parker

Stock data

Close
1.09 USD
Market cap
707.57M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States